Clinical Trial: Smart-tech empowerment for optimizing short-course chemotherapy plans for drug-sensitive tuberculosis in the elderly and a multicenter randomized controlled clinical study (Project 5: Clinical study of short-course treatment regimens for drug-sensitive tuberculosis in the elderly) (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Smart-tech empowerment for optimizing short-course chemotherapy plans for drug-sensitive tuberculosis in the elderly and a multicenter randomized controlled clinical study (Project 5: Clinical study of short-course treatment regimens for drug-sensitive tuberculosis in the elderly)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132820

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: Shanghai Public Health Clinical Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=334804

Published by HT Digital Content Services with permi...